CLDX
Price
$27.94
Change
-$0.25 (-0.89%)
Updated
Dec 11 closing price
Capitalization
1.86B
80 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$78.51
Change
+$0.63 (+0.81%)
Updated
Dec 11 closing price
Capitalization
15.18B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs RVMD

Header iconCLDX vs RVMD Comparison
Open Charts CLDX vs RVMDBanner chart's image
Celldex Therapeutics
Price$27.94
Change-$0.25 (-0.89%)
Volume$669.86K
Capitalization1.86B
Revolution Medicines
Price$78.51
Change+$0.63 (+0.81%)
Volume$2.02M
Capitalization15.18B
CLDX vs RVMD Comparison Chart in %
View a ticker or compare two or three
VS
CLDX vs. RVMD commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and RVMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (CLDX: $27.94 vs. RVMD: $78.51)
Brand notoriety: CLDX and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 78% vs. RVMD: 89%
Market capitalization -- CLDX: $1.86B vs. RVMD: $15.18B
CLDX [@Biotechnology] is valued at $1.86B. RVMD’s [@Biotechnology] market capitalization is $15.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 6 TA indicator(s) are bullish while RVMD’s TA Score has 2 bullish TA indicator(s).

  • CLDX’s TA Score: 6 bullish, 4 bearish.
  • RVMD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than RVMD.

Price Growth

CLDX (@Biotechnology) experienced а -5.61% price change this week, while RVMD (@Biotechnology) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($15.2B) has a higher market cap than CLDX($1.86B). RVMD YTD gains are higher at: 78.052 vs. CLDX (10.566). CLDX has higher annual earnings (EBITDA): -231.4M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. CLDX (630M). CLDX has less debt than RVMD: CLDX (3.03M) vs RVMD (133M). CLDX has higher revenues than RVMD: CLDX (5.79M) vs RVMD (0).
CLDXRVMDCLDX / RVMD
Capitalization1.86B15.2B12%
EBITDA-231.4M-883.71M26%
Gain YTD10.56678.05214%
P/E RatioN/AN/A-
Revenue5.79M0-
Total Cash630M2.14B29%
Total Debt3.03M133M2%
FUNDAMENTALS RATINGS
CLDX vs RVMD: Fundamental Ratings
CLDX
RVMD
OUTLOOK RATING
1..100
2031
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
8345
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
4136
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (69) in the Biotechnology industry is in the same range as RVMD (96) in the null industry. This means that CLDX’s stock grew similarly to RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for CLDX (83) in the Biotechnology industry. This means that RVMD’s stock grew somewhat faster than CLDX’s over the last 12 months.

CLDX's SMR Rating (95) in the Biotechnology industry is in the same range as RVMD (96) in the null industry. This means that CLDX’s stock grew similarly to RVMD’s over the last 12 months.

RVMD's Price Growth Rating (36) in the null industry is in the same range as CLDX (41) in the Biotechnology industry. This means that RVMD’s stock grew similarly to CLDX’s over the last 12 months.

RVMD's P/E Growth Rating (100) in the null industry is in the same range as CLDX (100) in the Biotechnology industry. This means that RVMD’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXRVMD
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 24 days ago
78%
Bearish Trend 23 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIDVX13.330.10
+0.76%
Janus Henderson U.S. Dividend Income I
REVCX14.130.09
+0.64%
Columbia Global Value C
FFNIX14.37N/A
N/A
Fidelity Advisor Asset Manager 40% I
DTLGX52.63N/A
N/A
Wilshire Large Company Growth Invmt
WFPAX49.37N/A
N/A
Allspring Special Mid Cap Value A

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-0.89%
XNCR - CLDX
55%
Loosely correlated
-0.58%
BEAM - CLDX
55%
Loosely correlated
+0.40%
RVMD - CLDX
54%
Loosely correlated
+0.81%
CRNX - CLDX
53%
Loosely correlated
+2.60%
KURA - CLDX
53%
Loosely correlated
-2.61%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.09%
NUVL - RVMD
60%
Loosely correlated
+0.62%
CGON - RVMD
56%
Loosely correlated
N/A
IDYA - RVMD
54%
Loosely correlated
-1.29%
CLDX - RVMD
54%
Loosely correlated
+0.36%
IRON - RVMD
54%
Loosely correlated
+1.23%
More